Raymond James upgraded Aveanna (AVAH) to Strong Buy from Outperform with an unchanged price target of $13. The firm views the current valuation as “a discount to precedent transactions” with BrightSpring Health (BTSG) having acquired home health assets from UnitedHealth (UNH) and the announced Enhabit (EHAB) go-private deal with a financial sponsor, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVAH: